高级检索
    马胜林, 李安娜. 司美替尼联合多西紫杉醇治疗KRAS突变阳性晚期非小细胞肺癌的疗效[J]. 循证医学, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
    引用本文: 马胜林, 李安娜. 司美替尼联合多西紫杉醇治疗KRAS突变阳性晚期非小细胞肺癌的疗效[J]. 循证医学, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
    shu
    MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
    Citation: MA Sheng-lin, LI An-na. Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 30-32. DOI: 10.3969/j.issn.1671-5144.2014.01.003
    shu

    司美替尼联合多西紫杉醇治疗KRAS突变阳性晚期非小细胞肺癌的疗效

    Efficacy of Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(6)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回